{"title":"3d视网膜类器官:为未来的治疗搭建平台。","authors":"Jessica N Mazerik, Steven Becker, Paul A Sieving","doi":"10.1177/2155179018773758","DOIUrl":null,"url":null,"abstract":"<p><p>Across scientific disciplines, 3-D organoid culture systems offer platforms to integrate basic research findings with clinical care. The National Eye Institute mounted a $1.1 million 3-D Retina Organoid Challenge. Organoids developed through the Challenge will be valuable resources for drug screening, disease modeling, and precision and regenerative medicine.</p>","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"10 ","pages":"2155179018773758"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2155179018773758","citationCount":"7","resultStr":"{\"title\":\"3-D retina organoids: Building platforms for therapies of the future.\",\"authors\":\"Jessica N Mazerik, Steven Becker, Paul A Sieving\",\"doi\":\"10.1177/2155179018773758\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Across scientific disciplines, 3-D organoid culture systems offer platforms to integrate basic research findings with clinical care. The National Eye Institute mounted a $1.1 million 3-D Retina Organoid Challenge. Organoids developed through the Challenge will be valuable resources for drug screening, disease modeling, and precision and regenerative medicine.</p>\",\"PeriodicalId\":9780,\"journal\":{\"name\":\"Cell medicine\",\"volume\":\"10 \",\"pages\":\"2155179018773758\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/2155179018773758\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/2155179018773758\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2155179018773758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
3-D retina organoids: Building platforms for therapies of the future.
Across scientific disciplines, 3-D organoid culture systems offer platforms to integrate basic research findings with clinical care. The National Eye Institute mounted a $1.1 million 3-D Retina Organoid Challenge. Organoids developed through the Challenge will be valuable resources for drug screening, disease modeling, and precision and regenerative medicine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
